Padma V. Devarajan

3.8k total citations · 1 hit paper
91 papers, 3.0k citations indexed

About

Padma V. Devarajan is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Padma V. Devarajan has authored 91 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmaceutical Science, 22 papers in Biomaterials and 18 papers in Molecular Biology. Recurrent topics in Padma V. Devarajan's work include Advanced Drug Delivery Systems (35 papers), Nanoparticle-Based Drug Delivery (21 papers) and Drug Solubulity and Delivery Systems (19 papers). Padma V. Devarajan is often cited by papers focused on Advanced Drug Delivery Systems (35 papers), Nanoparticle-Based Drug Delivery (21 papers) and Drug Solubulity and Delivery Systems (19 papers). Padma V. Devarajan collaborates with scholars based in India, United Kingdom and Colombia. Padma V. Devarajan's co-authors include Anisha D’Souza, Sanyog Jain, Vinod C. Malshe, Ganeshchandra S. Sonavane, Abdul Samad, Anil B. Jindal, Derajram Benival, Rajiv V. Gaikwad, Rishikesh Sawant and Vladimir P. Torchilin and has published in prestigious journals such as Food Chemistry, Journal of Controlled Release and Carbohydrate Polymers.

In The Last Decade

Padma V. Devarajan

91 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications

2015 459 citations Anisha D’Souza, Padma V. Devarajan Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Padma V. Devarajan India	31	1.0k	929	857	462	351	91	3.0k
Jitender Madan India	29	828 0.8×	736 0.8×	787 0.9×	376 0.8×	207 0.6×	148	2.6k
Manish K. Chourasia India	31	981 1.0×	1.0k 1.1×	1.7k 2.0×	543 1.2×	277 0.8×	114	4.4k
Cheong‐Weon Cho South Korea	37	1.2k 1.2×	944 1.0×	1.6k 1.9×	551 1.2×	293 0.8×	182	4.1k
Kaushik Thanki India	30	936 0.9×	784 0.8×	1.0k 1.2×	268 0.6×	161 0.5×	56	2.6k
Prabhat Ranjan Mishra India	34	1.3k 1.3×	891 1.0×	870 1.0×	581 1.3×	204 0.6×	126	3.5k
Rania M. Hathout Egypt	40	968 1.0×	818 0.9×	1.7k 2.0×	428 0.9×	335 1.0×	99	3.8k
Asadullah Madni Pakistan	31	813 0.8×	925 1.0×	840 1.0×	604 1.3×	176 0.5×	107	2.7k
Varun Kushwah India	34	895 0.9×	876 0.9×	1.1k 1.3×	434 0.9×	209 0.6×	88	2.8k
Eliana Martins Lima Brazil	32	1.1k 1.0×	1.1k 1.2×	1.2k 1.4×	651 1.4×	152 0.4×	128	3.6k
Ashish Kumar Agrawal India	35	2.4k 2.4×	859 0.9×	1.0k 1.2×	572 1.2×	305 0.9×	140	4.5k

Countries citing papers authored by Padma V. Devarajan

Since Specialization

Citations

This map shows the geographic impact of Padma V. Devarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Padma V. Devarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Padma V. Devarajan more than expected).

Fields of papers citing papers by Padma V. Devarajan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Padma V. Devarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Padma V. Devarajan. The network helps show where Padma V. Devarajan may publish in the future.

Co-authorship network of co-authors of Padma V. Devarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Padma V. Devarajan. A scholar is included among the top collaborators of Padma V. Devarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Padma V. Devarajan. Padma V. Devarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rani, Komal, et al.. (2024). Polydispersity-mediated high efficacy of an in-situ aqueous nanosuspension of PPEF.3HCl in methicillin resistant Staphylococcus aureus sepsis model. International Journal of Pharmaceutics. 655. 123982–123982. 1 indexed citations

Munshi, Renuka, et al.. (2023). pH-responsive microparticles of rifampicin for augmented intramacrophage uptake and enhanced antitubercular efficacy. International Journal of Pharmaceutics. 635. 122729–122729. 4 indexed citations

Devarajan, Padma V., et al.. (2023). Facile Technology for Extemporaneous Preparation of Long-Acting Injectable Microparticulate Suspensions at the Patient Side. AAPS PharmSciTech. 24(2). 61–61. 2 indexed citations

Devarajan, Padma V., et al.. (2022). In-silico approach as a tool for selection of excipients for safer amphotericin B nanoformulations. Journal of Controlled Release. 349. 756–764. 15 indexed citations

Devarajan, Padma V., et al.. (2021). Development and Optimization of Microballoons Assisted Floating Tablets of Baclofen. AAPS PharmSciTech. 22(8). 272–272. 5 indexed citations

Devarajan, Padma V., et al.. (2020). A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. European Journal of Pharmacology. 891. 173748–173748. 71 indexed citations

Patwardhan, Raghavendra S., et al.. (2020). Pre-clinical evaluation of an innovative oral nano-formulation of baicalein for modulation of radiation responses. International Journal of Pharmaceutics. 595. 120181–120181. 31 indexed citations

Dighe, Vikas, et al.. (2017). Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer’s patch uptake. International Journal of Pharmaceutics. 532(1). 612–622. 35 indexed citations

Syed, Asad, et al.. (2016). Nevirapine Loaded Core Shell Gold Nanoparticles by Double Emulsion Solvent Evaporation: In vitro and In vivo Evaluation. Current Drug Delivery. 13(7). 1071–1083. 12 indexed citations

10.

D’Souza, Anisha & Padma V. Devarajan. (2015). Bioenhanced oral curcumin nanoparticles: Role of carbohydrates. Carbohydrate Polymers. 136. 1251–1258. 29 indexed citations

11.

D’Souza, Anisha, et al.. (2015). In situ polyethylene sebacate particulate carriers as an alternative to Freund’s adjuvant for delivery of a contraceptive peptide vaccine — A feasibility study. International Journal of Pharmaceutics. 496(2). 601–608. 4 indexed citations

12.

D’Souza, Anisha, et al.. (2012). Inorganic nanovectors for nucleic acid delivery. Drug Delivery and Translational Research. 3(5). 446–470. 16 indexed citations

13.

Samad, Abdul, et al.. (2011). Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line. Cancer Nanotechnology. 2(1-6). 49–55. 22 indexed citations

14.

Malshe, Vinod C., et al.. (2009). Polyethylene sebacate: Genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. Journal of Pharmaceutical Sciences. 98(12). 4781–4795. 18 indexed citations

15.

Sawant, Rishikesh, et al.. (2006). Polyethylene glycol–phosphatidylethanolamine conjugate (PEG–PE)-based mixed micelles: Some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. International Journal of Pharmaceutics. 315(1-2). 148–157. 174 indexed citations

16.

Devarajan, Padma V., et al.. (1999). Feasibility of an In Vitro Microbiological Model as an Alternative to the Rabbit Eye Model. Drug Development and Industrial Pharmacy. 25(6). 781–788. 2 indexed citations

17.

Devarajan, Padma V., et al.. (1999). Comparative Pharmacodynamic-Pharmacokinetic Correlation of Oral Sustained-Release Theophylline Formulation in Adult Asthmatics. Drug Development and Industrial Pharmacy. 25(4). 529–534. 1 indexed citations

18.

Devarajan, Padma V., et al.. (1999). High-performance thin-layer chromatographic determination of theophylline in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 736(1-2). 289–293. 13 indexed citations

19.

Parmar, Dhruvanshu, et al.. (1997). High-performance thin-layer chromatographic determination of flurbiprofen in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 694(2). 449–453. 13 indexed citations

20.

Parmar, Dhruvanshu, et al.. (1997). High-performance thin-layer chromatographic determination of ibuprofen in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 690(1-2). 315–319. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact